Nova Capital Trading Announces Filing of Early Warning Report Related to Exercise of Warrants in the Capital of Glow Lifetech

On October 23, 2025, Nova Capital Trading Limited (the "Acquiror") announced the submission of an early warning report regarding the acquisition of 9,050,000 common shares in Glow Lifetech Corp. ("the Company") through the exercise of an equivalent number of common share purchase warrants (the "Warrants"). Prior to this acquisition, Nova Capital held approximately 27,036,167 common shares and 25,166,667 warrants, which constituted around 15.77% of the total outstanding shares on an undiluted basis and roughly 26.56% on a partially diluted basis.

Following the completion of the acquisition, the Acquiror’s holdings increased to a total of 36,086,167 common shares, representing about 20.00% of the total issued shares on an undiluted basis, while the partially diluted percentage remained at approximately 26.56%, given a reduced number of warrants. The acquisition reflects Nova Capital’s long-term investment strategy, as the common shares were acquired primarily for investment purposes.

The Acquiror has indicated a willingness to adjust its position in Glow Lifetech in response to market dynamics. This could involve purchasing more securities, whether in the open market or via private transactions, or potentially selling existing shares depending on future market conditions and strategic considerations.

For more comprehensive insights into the acquisition, interested parties can review the full report available on SEDAR+ or reach out to Roderick Forrest via email or phone for further inquiries. This acquisition may impact investor sentiment as Nova Capital's increased stake could suggest confidence in Glow Lifetech’s future prospects.

Nova Capital Trading Limited's recent early warning report regarding its substantial acquisition of Glow Lifetech Corp. shares serves as an important indicator for market analysts and investors. After exercising 9,050,000 warrants, Nova now holds approximately 20% of Glow's total outstanding common shares. This heightened stake reflects Nova’s confidence in Glow Lifetech's potential, suggesting that they anticipate significant growth or value appreciation in the company.

For investors, this acquisition provides several insights into market sentiment and strategic positioning. First, Nova Capital’s investment appears to be a long-term strategy, which indicates that they believe in the sustainable growth prospects and operational resilience of Glow Lifetech. As disclosed, Nova may continue to acquire more shares depending on market conditions, which could lead to increased demand and volatility for Glow's shares in the near future.

It is advisable for interested investors to monitor Glow Lifetech closely for any changes in market sentiment. If additional share purchases occur from Nova or if they decide to sell some of their holdings, those actions could significantly impact the stock price and investor sentiment.

Moreover, there may be opportunities to enter or exit positions based on market reactions related to this news. Investors should also pay attention to the performance of Glow Lifetech’s broader offerings and how they align with market trends, particularly given the increasing focus on health and wellness products.

In summary, while the acquisition is a positive signal, it is essential to maintain a cautious approach. Analyzing market conditions and Glow Lifetech's performance trajectory will be key for making informed investment decisions moving forward.